Why Global Top‐Tier Teams Choose Chinese Research‐Reagent Brand?. Rigorous validation in metabolism, oncology immunology and gut‐brain‐axis research proves Cloud‐Clone antibodies' global‐competitive ...

Boost ROI with validated antibodies, standardized workflows, multiplex digital pathology, governed AI, regional support and reliable supplyDublin, Sept. (GLOBE NEWSWIRE) -- "TDP43 Antibody Market - ...

骨质疏松性骨缺损修复一直是临床领域的重大挑战 —— 骨生成能力下降、血管新生紊乱、支架整合效果差等问题，让无数患者面临骨折难愈、残疾风险升高的困境。近期，《Bioactive Materials》发表重磅研究，提出一种 “力学 - 生物活性解耦” ...

Peanut allergy affects roughly two percent of people in Western countries and about 2.2 percent worldwide, and its prevalence ...

Creative Diagnostics launches Environmental Toxicology Biomarker Antibodies to support researchers in investigating the biological effects of chemical exposure in aquatic organisms and wildlife.

New therapeutic strategies against P. aeruginosa are urgently needed. Polyclonal antibodies (pAbs) may provide broader coverage than mAbs by recognizing multiple bacterial epitopes and reducing immune ...

While heart transplantation (HT) is the optimal therapy for end-stage heart failure patients, longevity of HT recipients ...

Immuron has exceeded sales projections with second half growth of 7% on the prior comparative period (pcp) and record FY26 sales of A$7.7 million, growth of 6% on pcp.

A relatively new form of immunotherapy is changing the way some cancers are treated and expanding options for patients who have exhausted traditional treatments. Bispecific antibody therapy is gaining ...

Detailed price information for Immuron Ltd ADR (IMRN-Q) from The Globe and Mail including charting and trades.

Detailed price information for Immuron Ltd ADR (IMRN-Q) from The Globe and Mail including charting and trades.